prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - gripas vīrusa virsmas antigēnu (hemaglutinīna un neiraminidāzes) celma a/vjetnama/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vakcīnas - aktīvā imunizācija pret a gripas vīrusa h5n1 apakštipa. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
leponex 25 mg tabletes
novartis (hellas), greece - klozapīns - tablete - 25 mg
leponex 100 mg tabletes
novartis (hellas), greece - klozapīns - tablete - 100 mg
lescol xl 80 mg ilgstošās darbības tabletes
novartis (hellas) a.e.b.e., greece - fluvastatīns - ilgstošās darbības tablete - 80 mg
trileptal 600 mg apvalkotās tabletes
novartis (hellas) a.e.b.e., greece - okskarbazepīns - apvalkotā tablete - 600 mg
sandostatin 0,1 mg/ml šķīdums injekcijām/infūziju šķīdums
novartis (hellas) a.e.b.e., greece - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml
sandostatin 0,1 mg/ml šķīdums injekcijām/šķīdums infūzijām
novartis (hellas) a.e.b.e., greece - oktreotīds - Šķīdums injekcijām/infūzijām - 0,1 mg/ml
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).
tobrex 0,3% acu ziede
novartis (hellas) a.e.b.e., greece - tobramicīns - acu ziede - 3 mg/g
lamisil 1% krēms
novartis (hellas) a.e.b.e., greece - terbinafīna hidrohlorīds - krēms - 1%